Related Experiment Video
Updated: Mar 18, 2026

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
Are there "Attenuated" Forms of Evans Syndrome?
G J Ruiz-Argüelles1,2, B López-Martínez1, E Estrada3
1a Centro de Hematología y Medicina Interna de Puebla , Díaz Ordaz 808, 72530 Puebla , Mexico.
This study found that low free haptoglobin levels, indicating red blood cell destruction (hemolysis), were present in 29% of patients with autoimmune thrombocytopenic purpura, suggesting a link to Evans syndrome.
Area of Science:
- Hematology
- Immunology
Background:
- Autoimmune thrombocytopenic purpura (ITP) can be associated with hemolysis.
- Assessing red blood cell destruction in ITP patients requires further investigation.
Purpose of the Study:
- To investigate red blood cell destruction in ITP patients using free haptoglobin levels.
- To explore the relationship between hemolysis and long-term outcomes in ITP.
Main Methods:
- Measured free haptoglobin levels in 17 ITP patients.
- Excluded other causes of hemolysis like microangiopathic hemolysis, systemic lupus erythematosus, and Evans syndrome.
Main Results:
- Abnormally low free haptoglobin levels, indicating hemolysis, were found in 29% of ITP patients.
- Patients with low haptoglobin levels had a lower long-term thrombocytopenia-free status (40% vs. 58%).
Conclusions:
- Low free haptoglobin levels provide indirect evidence of hemolysis in a subset of ITP patients.
- These findings support a spectrum between primary thrombocytopenia and hemolytic anemia, suggesting "attenuated" Evans syndrome variants.
Related Concept Videos
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Sex-linked Disorders
EPS and iPS Cells in Disease Research
Subviral Agents
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

